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ABSTRACT 32 
Background: By exercising, an inflammatory response of the airways occurs, with 33 
bronchial smooth muscle constriction and vasodilatation. The later could lead to an 34 
increase in exhaled breath temperature (EBT), possibly more pronounced in subjects 35 
with asthma. We aim to investigate the effect of a training session on EBT of elite 36 
swimmers and to assess if the impact is different in asthmatic vs non-asthmatic 37 
swimmers.  38 
Methods: Swimmers that are annually screened for asthma in our Department were 39 
invited to this prospective study. The regular screening includes 2 visits in which 40 
subjects perform skin prick tests, spirometry before and after salbutamol inhalation and 41 
bronchial challenge with methacholine. Diagnosis of asthma was according to IOC-MC 42 
criteria. For those who agreed to participate, EBT was measured with X-halo 43 
thermometer before and after a training session. SPSS (p<0.05) was used to compare 44 
baseline and post-training EBT; and ∆EBT between asthmatic and non-asthmatic 45 
swimmers.  46 
Results: 22 swimmers accepted to participate, of which 10 had asthma. EBT 47 
significantly increased after the training session (p=0.020). No significant differences 48 
were observed in mean ∆EBT among asthmatic and non-asthmatic swimmers 49 
(p=0.222).  50 
Conclusions: EBT increased after a training session. There was no difference in EBT 51 
between asthmatics and non-asthmatics.  52 
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INTRODUCTION 63 
Asthma is defined as a clinical syndrome of intermittent respiratory symptoms triggered 64 
by viral infections, environmental allergens, or other stimuli, and is characterized by 65 
nonspecific airway hyperesponsiveness and inflammation (1). Vasodilatation is a 66 
critical feature of inflammation, and angiogenesis and vascular remodeling are features 67 
of chronic inflammatory diseases, such as asthma (2). The increased vascularity of the 68 
airways in asthma is partly due to the elevated number of vessels associated with 69 
angiogenesis (3) and partly due to vasodilation caused by the release of vasodilator 70 
mediators, such as histamine, bradykinin and nitric oxide (NO). 71 
As part of this inflammatory process, the increased vascularization of the airway 72 
mucosa that occurs in asthmatics, leads to increased heat exchange during expiration 73 
(4) and previous studies have reported that patients with asthma present an elevated 74 
exhaled breath temperature (EBT) compared to healthy controls (5). The elevation of 75 
exhaled NO as an inflammatory marker seen in asthmatics, has previously been shown 76 
to correlate with increased EBT (5, 6), and therefore EBT has been proposed as a non-77 
invasive new biomarker for asthma control (7, 8).  78 
Although the pathogenesis of the association of sports practice and airway injury is not 79 
fully elucidated, some hypotheses have been proposed, one of which focuses upon 80 
cooling of the airways caused by hyperpnea during exercise. Vigorous exercise 81 
requires an increased ventilatory rate to meet higher muscular oxygen needs, which 82 
results in the inhalation of a large volume of relatively cold and dry air and the loss of 83 
heat from the respiratory mucosa. This mechanic noxious stimulus could cause 84 
epithelial damage, and therefore the influx of inflammatory cells and their mediators 85 
release (9-11). Also, higher levels of airway vascular permeability have been shown to 86 
be a good predictor of the severity of EIA in asthmatics, which has led to the 87 
microvascular theory of EIA based on functional abnormalities of endothelial cells in 88 
newly generated microvessels in asthmatic airways (12). 89 
It has been shown a significant increase in EBT in asthmatic children after exercise 90 
(13), but this increase is not different between asthmatics and controls (14). In athletes 91 
this was never investigated before and is a relevant issue as they present an increased 92 
risk for asthma, especially those who take part in endurance sports, such as swimming 93 
(10). We hypothesize that exercise would increase EBT, and a more pronounced 94 
increase in would be seen in asthmatic athletes as a greater degree of response to 95 
exercise as compared to healthy ones. Therefore, our aim was to investigate the effect 96 
of a training session on EBT of elite swimmers, and to assess if the impact is different 97 
in asthmatic vs non-asthmatic swimmers. 98 
 99 
METHODS 100 
Study design and subjects 101 
Elite swimmers of the FC Porto main swimming team who are annually screened for 102 
asthma and atopy at Allergy, Asthma and Sports Unit were invited to participate in this 103 
prospective study. The regular screening includes two visits, about 1 week apart, in 104 
which subjects are evaluated with skin prick tests, lung volumes before and after 105 
salbutamol inhalation, and airway responsiveness to methacholine. Swimmers are 106 
asked to withheld anti-asthmatic or anti-allergic medication that they might being 107 
possibly taking for both visits, according to European Respiratory Society guidelines 108 
(15). Inhaled short acting β2-agonists were withheld for 8 hours before testing; inhaled 109 
long-acting β2-agonists, theophylline, and leukotriene antagonists were withheld for the 110 
last 72 hours; antihistamines were withheld for the last 7 days; and both inhaled and 111 
orally administered corticosteroids were withheld for the last month. At that time, they 112 
are diagnosed as having or not asthma, according to International Olympic Committee 113 
criteria (16). Later, for those who agreed to participate in the study, EBT was collected 114 
before and after a training session at their swimming pool.  115 
In order to be eligible to participate in this study, a subject had to meet all the following 116 
criteria: elite level swimmer; free from respiratory infection in the last 3 weeks; provided 117 
signed and dated informed consent. A potential subject who met any of the following 118 
criteria was excluded from participation in this study: pregnancy; recent episode of 119 
hemoptysis; forced expiratory volume in the first second (FEV1) lower than 60% of the 120 
predicted value or 1.5 L; neurological or psychiatric illness; lack of collaboration or 121 
coexistence of diseases that limit the patient's ability to carry out the tests; recent 122 
stroke or heart attack.  123 
All subjects gave written informed consent, and the study was approved by ethical 124 
commission of Centro Hospitalar São João / Faculdade de Medicina da Universidade 125 
do Porto.  126 
Procedures 127 
Methacholine challenge 128 
Non-specific bronchial hyperesponsiveness was measured by methacholine challenge, 129 
according to guidelines (15). Methacholine was delivered by inspiration triggered by an 130 
automatic dosimeter that delivers a single dose soon after the onset of a deep breath. 131 
The five-breath dosimeter method was used and the provocative dose causing a 20% 132 
fall in FEV1 (PD20) was determined. 133 
Lung function 134 
Spirometry was carried out according to the American Thoracic Society criteria (17). 135 
Lung function measurements were repeated 15 minutes after 400 μg of salbutamol in 136 
aerochamber to assess reversibility.  137 
Skin prick tests 138 
Skin prick tests were carried out in accordance international guidelines (18) with a 139 
standard battery of commercial extracts for common aeroallergens (Leti®, Madrid, 140 
Spain). Histamine dihydrochloride and diluent were used as positive and negative 141 
controls, respectively. Testing solutions were stored at +2 to +8ºC when not in use. The 142 
largest and perpendicular diameter of the wheal for each of the allergens is measured 143 
and the following value calculated: largest + perpendicular diameter/2. A subject is 144 
defined as atopic in the presence of at least one positive result (regarded if the value 145 
calculated was ≥3 mm and controls showed adequate reactions) (18).  146 
Exhaled breath temperature 147 
EBT was measure using an X-halo device (Delmedica Investments, Singapore), 5 148 
minutes before (baseline EBT) and 5 minutes after (post-exercise EBT) the swimming 149 
training session, according to previously validated methods (20). Briefly, the swimmers 150 
were requested to inhale freely through the nose and to exhale into the device at a rate 151 
and depth typical of their normal tidal breathing rhythm. The maneuver was continued 152 
until the built-in software of the instrument indicated that the measured value was 153 
stable. The decision of collecting EBT 5 minutes after the exercise was based in 154 
previous studies that have shown that this was the time point in which EBT reached the 155 
highest values, and decreases thereafter (14). 156 
The time needed to achieve the stable EBT was recorded. Before and between 157 
measures, the device was kept at room temperature in order to maintain a stable 158 
starting temperature.  159 
The swimmers performed their regular training session and no changes were imposed 160 
by the investigators. The intensity of the training session was recorded (categorized as 161 
1: mild aerobic training; 2: moderate/intense aerobic training; 3: mild anaerobic training; 162 
and 4: moderate/intense anaerobic training) in order to identify a possible confounding 163 
effect. The training was performed at a chorine disinfected open-air swimming-pool. 164 
Body temperature 165 
Oral temperature has been proposed to be related to the airways and/or the oral cavity, 166 
as both are part of the respiratory tract and are affected differently than systemic 167 
temperature during exercise (14), and therefore we have chosen axillary temperature 168 
to evaluate body temperature. It was measured with an axillary thermometer 169 
(MedCare®) before collecting baseline EBT. 170 
Statistical analysis 171 
Categorical variables are expressed as counts (%) and continuous variables as mean 172 
(standard deviation - SD) or, if not normally distributed, as median (interquartile range - 173 
IQR). Paired samples t-test was used to compare the differences between baseline 174 
and post-exercise EBTs. Differences between asthmatic and non-asthmatic swimmers 175 
were assessed with independent samples t-test for normally distributed data, Mann-176 
Whitney for non-normally distributed data or Chi-Square for categorical variables. A 177 
new variable was created ( EBT = post exercise EBT – baseline EBT), and used to 178 
assess if the variation of EBT was different among asthmatic and non-asthmatic 179 
subjects. Correlations were assessed with Spearman’s test.  180 
All analyses were performed using SPSS and STATA and considering a p<0.05 for 181 
statistical significance. 182 
 183 
RESULTS 184 
Twenty-two elite swimmers accepted to participate, of which 10 had asthma. No 185 
differences were observed between asthmatic and non-asthmatic swimmers for 186 
demographic and personal characteristics, except for the expected lower PD20 among 187 
those with asthma (table 1).   188 
Table 1:  189 
Demographic and personal characteristics 190 
 
Asthmatics 
(n=10) 
Controls 
(n=12) 
p 
Men, n (%) 7 (70) 3 (23) 0.084 
Age  17 ± 2.8 17 ± 2.9 0.946 
Atopy, n (%) 4 (40)  4 (33) 1.000 
PD20 methacholine 0.71 ± 0.6 4.39 ± 2.4 <0.001 
FEV1, Liters 4.26 ± 0.75 4.07 ± 0.92 0.622 
FEV1, % of predicted 111.10 ± 14.54 115.50 ± 8.89 0.393 
FVC, Liters 5.13 ± 0.94 4.60 ± 1.20 0.271 
FVC, % of predicted 114.50 ± 10.49 114.08 ± 11.48 0.931 
FEV1/FVC 83.52 ± 7.32 89.36 ± 7.18 0.074 
FEF25-75, Liters 4.22 ± 1.20 4.67 ± 1.17 0.387 
FEF25-75, % of predicted 97.3 ± 26.67 113.42 ± 22.54 0.140 
Data presented as mean±SD, unless otherwise stated.  191 
FEF2575: forced expiratory flow middle portion of FVC; FEV1: forced expiratory volume in one second; 192 
FVC: forced vital capacity; L: liters; PD20: provocative dose inducing a 20% decrease in FEV1.  193 
Exhaled breath temperature 194 
Baseline and post-exercise EBT were not significantly different between asthmatic and 195 
healthy swimmers (table 2). EBT significantly increased after exercise in all subjects 196 
(p=0.020) (figure 1). This increase ( EBT) was not significantly different among 197 
asthmatic swimmers and the healthy ones (p=0.222) (figure 2). Correlation between 198 
PD20 and EBT for asthmatic swimmers was not significant (r=-0.103, p=0.777). 199 
Because 6 (60%) asthmatic swimmers were under therapeutic with inhaled 200 
corticosteroids at the time of EBT collection, a second analysis was performed and no 201 
differences were observed between those with and without therapy (p=0.853).  202 
Correlations between axillary temperature and both baseline and post-exercise EBTs 203 
were not significant (p=0.972 and p=0.597, respectively). 204 
Regarding time to collect EBT, no differences were observed from baseline to post-205 
exercise measurements in the global sample (p=0.822). Also, for baseline EBT 206 
collection, no differences occurred between asthmatic and non-asthmatic swimmers 207 
(p=0.366). However, for EBT collection after exercise, asthmatic swimmers took 208 
significantly less time to complete the measurement (4.2±0.79 vs 5.0±0.85 min, 209 
p=0.035). 210 
Training  211 
No significant differences were observed between asthmatic and controls regarding the 212 
intensity of the training session performed (table 2). The number of hours trained in the 213 
week of EBT collection was similar in the two groups (table 2).  214 
Table 2: 215 
Temperatures measurements and training evaluation 216 
 
Asthmatic swimmers 
(n=10) 
Healthy swimmers 
(n=12) 
p 
Baseline EBT, ºC 34.08 ± 0.60 33.49 ± 0.95 0.102 
Post-exercise EBT, ºC 34.23 ± 0.55 33.94 ± 0.64 0.275 
Body Temperature* 35.97 ± 0.42 36.02 ± 0.31 0.769 
Hours of training in that week 9.4 ± 2.6 9.3 ± 3.4 0.910 
Intensity of the session, n   0.121
#
 
Mild aerobic 8 3  
Moderate/severe aerobic 1 0  
Mild anaerobic 1 5  
Moderate/severe anaerobic 2 2  
Data presented as mean±SD, except otherwise stated. *Axillary temperature was used as a measure for 218 
body temperature. 
#
Chi-square test.  219 
DISCUSSION 220 
The hypothesis on the basis of this study was that elite swimmers would present 221 
increased EBT after a training session, due to the previously suggested idea that 222 
exercise would cause inflammation, and furthermore that asthmatic swimmers would 223 
experience a higher increase when compared to healthy controls. Interestingly, this 224 
could not be confirmed by this study. Although EBT was significantly increased in all 225 
subjects after training, supporting the hypothesis of heat loss during exercise, no 226 
differences were observed between swimmers with previously diagnosed asthma and 227 
healthy controls. It is therefore tempting to speculate that the theory of the heat loss as 228 
an ethiopathogenic mechanism of exercise-induced asthma lacks evidence.  229 
Our study has some limitations. The sample size might under power the study to draw 230 
solid conclusions. Moreover, a cause that may have affected the results could be the 231 
20 minutes of recovery (swimming with low effort) that swimmers made in the end of 232 
the training session and that decreases cardiac rhythm, respiratory frequency and the 233 
hyperpnea that makes EBT increase. If the temperature has been taken in the end of a 234 
more vigorous exercise instead at the end of the training this could lead to a marked 235 
results in EBT. 236 
Our results are consistent with previous studies that also have show an increase in 237 
EBT after exercise (13), but no differences between asthmatic subjects and healthy 238 
controls (14). That was different of other studies that shown differences in EBT of 239 
asthmatic patients compared to healthy controls (5). This raises the question whether 240 
the EBT could be a good inflammatory biomarker of asthmatics.  241 
Previously has been hypothesized that dehydration of the airways with increased 242 
osmolality in the mucosal surface liquid leads to mast cell degranulation (21, 22), 243 
releasing bronchoconstriction mediators, such as bradykinin and histamine, and 244 
activating endothelial nitric oxide synthase (23), witch increase the vasodilation effect. 245 
This could suggest that elevated EBT could be a potential marker of a temporary effect 246 
on the airways, rather than of the long-term inflammation of the asthmatic disease. So 247 
the increase of EBT could be a physiological response of the airways to the increase of 248 
ventilatory rate, rather than a pathological pathway which can be involved in 249 
development of exercise-induced asthma. 250 
This study leads us to hypotheses that the increase of EBT and there for the elevation 251 
of airway inflammation shown in previous studies (5, 6), during exercise (13), could be 252 
a protect measure of the airways against heat loss and dehydration, that occurs with 253 
the increase of ventilatory rate, rather than a pathological result. 254 
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